Open Access
| Issue |
E3S Web Conf.
Volume 185, 2020
2020 International Conference on Energy, Environment and Bioengineering (ICEEB 2020)
|
|
|---|---|---|
| Article Number | 03037 | |
| Number of page(s) | 7 | |
| Section | Medical Biology and Medical Signal Processing | |
| DOI | https://doi.org/10.1051/e3sconf/202018503037 | |
| Published online | 01 September 2020 | |
- Ji Y. A 200-year history of Alzheimer’s disease. Chin J Contemp Neurol Neurosurg. 2014; 14(3):156. [Google Scholar]
- Alzheimer’s Disease International. Dementia statistics. 2015 https://www.alz.co.uk/research/statistics [Google Scholar]
- Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron. 1989; 3(4):519–26. [CrossRef] [PubMed] [Google Scholar]
- Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol. 1978; 4(4):273–7. [CrossRef] [PubMed] [Google Scholar]
- Sun X, Jin L, Ling P. Review of drugs for Alzheimer’s disease. Drug Discov Ther. 2012; 6(6):285–90. [PubMed] [Google Scholar]
- Nordberg A, Svensson AL. Cholinesterase inhibitors in the treatment of Alzheimer’s disease: a comparison of tolerability and pharmacology. Drug Saf. 1998; 19(6):465–80. [CrossRef] [PubMed] [Google Scholar]
- Cummings JL, Morstorf T, Zhong K. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014; 6(4):37. [CrossRef] [PubMed] [Google Scholar]
- Hefti F, Weiner WJ. Nerve growth factor and Alzheimer’s disease. Ann Neurol. 1986; 20(3):275–81. [CrossRef] [PubMed] [Google Scholar]
- Jones L, Holmans PA, Hamshere ML, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer’s disease. PLoS One. 2010; 5(11):e13950. [CrossRef] [PubMed] [Google Scholar]
- Jafarian-Tehrani M, Sternberg EM. Animal models of neuroimmune interactions in inflammatory diseases. J Neuroimmunol. 1999; 100(1-2):13–20. [CrossRef] [PubMed] [Google Scholar]
- Prince JL, Links JM. Medical imaging signals and systems. Upper Saddle River: Pearson Prentice Hall; 2006. [Google Scholar]
- Simard PY, Steinkraus D, Platt JC. Best practices for convolutional neural networks applied to visual document analysis. Seventh International Conference on Document Analysis and Recognition, 2003. Proceedings. [Google Scholar]
- Kotsiantis SB, Zaharakis I, Pintelas P. Supervised machine learning: A review of classification techniques. Frontiers in Artificial Intelligence and Applications. 2007; 160:3–24. [Google Scholar]
- Hosseini-Asl E, Keynton R, El-Baz A. Alzheimer’s disease diagnostics by adaptation of 3D convolutional network. 2016 IEEE International Conference on Image Processing (ICIP). 2016: 126–130. [Google Scholar]
- He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR). 2016:770–778. [Google Scholar]
- Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010; 74(3): 201–9. [Google Scholar]
- Jack CR Jr, Bernstein MA, Fox NC, et al. The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008; 27(4): 685–91. [CrossRef] [PubMed] [Google Scholar]
- https://github.com/jbrown81/ADNI_kaggle/blob/master/adni_kaggle.ipynb [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.